Khiron Life Sciences prices offering of common shares at $0.90
Khiron Life Sciences (TSXV: KHRN) has priced and sized its previously announced marketed offering of common shares at a price of $0.90 per share to raise aggregate gross proceeds of up to $11,250,000. KHRN has filed an amended and restated preliminary short form prospectus with the securities regulatory authorities in each of the provinces of Canada, other than Québec. The Company expects to file the final short form prospectus in respect of the Offering on or about September 6, 2018 and to close the Offering on or about September 13, 2018.
The Offering will be through a syndicate of agents on a best efforts basis led by Canaccord Genuity and including GMP Securities, Sprott Private Wealth LP, and Cormark Securities (see full news report here).